NEW: Colorado State University embarking on follow up dose finding study of cannabidiol in dogs with intractable epilepsy. For more information or to enroll:
________________________________
Researchers at the Warsaw Zoo in Poland have launched a project to check whether cannabis-extract oil will reduce anxiety in the zoo's elephants. For more information:
https://www.cnn.com/2020/08/27/europe/elephants-stressed-cbd-poland-scli-intl-scn/index.html
https://www.bbc.com/news/world-europe-53907689
________________________________
CannPal announces completion of its safety and efficacy study on Dermacann®, which reduces atopic dermatitis symptoms in dogs. For more information:
https://hempgazette.com/news/cannpal-cbd-dogs-hg1224/
For preliminary results, see the announcement freely accessible online by clicking the link in the above press release, or directly below:
http://cannpal.listedcompany.com/newsroom/20200721_44kpjjlhm8r3bz.pdf
_________________________________________
NEW: Tarleton State University’s Equine Center, part of the Texas A & M University system, seeks to quantify how CBD affects inflammation, stress and stereotypical negative behaviors in horses. For more information:
https://today.tamu.edu/2020/02/12/hemp-for-horses-tarleton-researcher-investigating-benefits/
___________________________________________
University of Saskatchewan's Western College of Veterinary Medicine will undertake research to study whether cannabis can be used to prevent chronic vomiting in dogs and cats. For more information:
_______________________________________________
University of Guelph will undertake a three-year study exploring the efficacy of cannabis for treating bladder cancer in dogs. For more information:
_______________________________________________
CannPal progressing canine cannabinoid trials. (Phase 2A pilot dose determination study for canine osteoarthritis and DermaCann trial starting soon.) For more information:
https://hempgazette.com/news/cannpal-cannabis-trials-hg0971/
_____________________________________________
Penn Vet to study hemp-based supplement. For more information:
https://www.veterinarypracticenews.com/penn-vet-study-hemp-based-canine-supplement/
_______________________________________________
Canopy Growth announces clinical trial approval for the use of cannabis to treat anxiety in certain animals. For more information:
https://www.canopygrowth.com/wp-content/uploads/2018/08/20180802_CAH-Anxiety-Study-NR-Final-EN-1.pdf
CannPal Animal Therapeutics commences Phase 1B of the Pharmacokinetic and Safety study for CPAT-01D, a cannabis-derived pain control for dogs. For more information:
*Click this link for a press release regarding preliminary results on this study. (At the bottom, there is a freely accessible link to the results presentation and research abstract from the 2019 Australian Veterinary Association)